This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. advanced 5.0% to $2.10 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.7% to 19,242.61 and the Dow Jones Industrial Average rising 0.1% to 42,305.48.
Inovio Pharmaceuticals Inc. closed 83.0% below its 52-week high of $12.33, which the company achieved on July 26th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 0.1% to $155.40, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.13% to $23.46.
Trading volume totaled 693,545, compared to the 50-day average of 648,331.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 02, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。